Indications for RHOPRESSA:
Open-angle glaucoma. Ocular hypertension.
≥18yrs: Instill 1 drop into the affected eye(s) once daily in the PM.
<18yrs: not established.
Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.
Rho kinase inhibitor.
Allow at least 5mins between application of other topical oph agents.
Conjunctival hyperemia, corneal verticillata, instillation site pain/erythema, conjunctival hemorrhage, corneal staining, blurred vision, increased lacrimation, erythema of eyelid, reduced visual acuity; bacterial keratitis.
Generic Drug Availability: